$35.24
-0.620 (-1.73%)
At Close: Jul 31, 2026
Harmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
07:30am, Thursday, 22'nd Feb 2024
WAKIX® (pitolisant) Net Revenue of $168.4 Million for Fourth Quarter and $582.0 Million for Full Year 2023; Representing Growth of ~31% and ~33%, Respectively
U.S. FOOD AND DRUG ADMINISTRATION GRANTS PRIORITY REVIEW TO HARMONY BIOSCIENCES' APPLICATION FOR WAKIX® (PITOLISANT) IN PEDIATRIC NARCOLEPSY
08:05am, Wednesday, 21'st Feb 2024
Prescription Drug User Fee Act date is June 21, 2024 PLYMOUTH MEETING, Pa., Feb. 21, 2024 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) announced that the U.S. Food and Drug Admini
HARMONY BIOSCIENCES RECEIVES U.S. FOOD AND DRUG ADMINISTRATION ORPHAN DRUG DESIGNATION FOR PITOLISANT IN PRADER-WILLI SYNDROME
08:05am, Tuesday, 20'th Feb 2024
PLYMOUTH MEETING, Pa. , Feb. 20, 2024 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug designation
The 3 Most Undervalued Small-Cap Stocks to Buy in February 2024
09:28am, Monday, 12'th Feb 2024
There are many types of companies in the financial markets, firstly from different sectors, and secondly, they can vary according to their capitalization size. Their capitalization can go by various f
HARMONY BIOSCIENCES TO REPORT FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS ON FEBRUARY 22, 2024
08:05am, Thursday, 08'th Feb 2024
PLYMOUTH MEETING, Pa. , Feb. 8, 2024 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that it will report fourth quarter and full year 2023 financial results on Thurs
HRMY or ILMN: Which Is the Better Value Stock Right Now?
12:41pm, Wednesday, 07'th Feb 2024
Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Harmony Biosciences Holdings, Inc. (HRMY) and Illumina (ILMN). But which of these two stocks present
The 3 Most Undervalued Russell 2000 Stocks to Buy in February 2024
12:36pm, Wednesday, 07'th Feb 2024
When it comes to undervalued Russell 2000 stocks, the narrative for targeting this specific space is the same as any other market-based motivation: buy low, sell high. It's just that with the Russell
Wall Street Analysts Believe Harmony Biosciences Holdings, Inc. (HRMY) Could Rally 28.77%: Here's is How to Trade
10:56am, Tuesday, 23'rd Jan 2024
The mean of analysts' price targets for Harmony Biosciences Holdings, Inc. (HRMY) points to a 28.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, stro
HRMY vs. RGEN: Which Stock Is the Better Value Option?
12:41pm, Monday, 22'nd Jan 2024
Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Harmony Biosciences Holdings, Inc. (HRMY) and Repligen (RGEN). But which of these two st
Bears are Losing Control Over Harmony Biosciences Holdings, Inc. (HRMY), Here's Why It's a 'Buy' Now
11:18am, Friday, 12'th Jan 2024
Harmony Biosciences Holdings, Inc. (HRMY) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate
Does Harmony Biosciences Holdings, Inc. (HRMY) Have the Potential to Rally 32.19% as Wall Street Analysts Expect?
11:18am, Friday, 05'th Jan 2024
The average of price targets set by Wall Street analysts indicates a potential upside of 32.2% in Harmony Biosciences Holdings, Inc. (HRMY). While the effectiveness of this highly sought-after metric
All You Need to Know About Harmony Biosciences Holdings, Inc. (HRMY) Rating Upgrade to Buy
01:32pm, Thursday, 04'th Jan 2024
Harmony Biosciences Holdings, Inc. (HRMY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near
HRMY or ACAD: Which Is the Better Value Stock Right Now?
12:47pm, Thursday, 04'th Jan 2024
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Harmony Biosciences Holdings, Inc. (HRMY) or Acadia Pharmaceuticals (ACAD). But which of thes
HARMONY BIOSCIENCES TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
08:05am, Wednesday, 03'rd Jan 2024
PLYMOUTH MEETING, Pa. , Jan. 3, 2024 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializin
Why Harmony Biosciences Stock Got Slammed Today
06:38pm, Tuesday, 02'nd Jan 2024
An analyst downgraded his recommendation on the biotech. He now rates it as a sell, where previously he felt it was a neutral.
Sign In
Buy HRMY